Austrian sarcopenia biobank study
Part of Brain & nervous system clinical trials.
This study collects blood and tissue samples from people with sarcopenia (muscle loss). It uses CT or MRI scans you already have planned to see how muscle changes over time. Your samples help researchers understand why muscle loss happens and how to treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are willing to donate a blood or tissue sample.
- You have a CT or MRI scan scheduled as part of your regular care within about 2 months of the study visit.
- You do not have severe confusion or cognitive problems that would prevent you from giving consent.
- You do not have advanced liver cancer (BCLC C or D).
- You do not have any other condition that, in the doctor's opinion, would make it hard for you to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the gut microbiome (the helpful bacteria in your gut) and muscle loss (sarcopenia) in people with liver cirrhosis. It may help researchers understand what changes in the gut and body can go along with getting weaker, so better treatments can be developed.
This study is testing a new digital system to help diagnose and manage sarcopenia (age-related muscle loss). It aims to make it easier for doctors to track and treat muscle loss, which can improve your strength and quality of life.
This study looks at muscle changes in people with or at risk for sarcopenia (age-related muscle loss). It aims to find better ways to detect and manage sarcopenia using simple tests like muscle strength and body composition measurements.
This trial tests a new approach to treat sarcopenia (age-related muscle loss) by targeting a protein called HIF-1α. It compares older adults with sarcopenia to younger adults without it, all of whom are having hip or knee surgery.
This study looks at the reasons for age-related muscle loss (sarcopenia) in people with heart failure. It may help researchers understand what is causing muscle weakness and how it could be treated in the future.
This study looks at how muscle loss (sarcopenia) might affect side effects from cancer treatments. If you are starting a new cancer treatment, a CT scan before treatment can help doctors predict your risk of side effects.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.